Clinical Trial Update: Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection [Phase 2]

View source ↗

Summary

Phase II study evaluating a regimen for stage IIIA non-small cell lung cancer. The trial uses induction therapy followed by surgical resection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Non-small Cell Lung Cancer Stage IIIA | Phase 2 | Status: UNKNOWN